The Gap: Affordable Basics Are Winning The Day — Positive

GAP   Seeking Alpha — December 19, 2025

The Gap, Inc. is capitalizing on affordability trends, driving comp sales acceleration amid sector-wide consumer spending weakness. GAP's lowest-priced label, Old Navy, is leading market share gains against higher-priced competitors. Year-to-date, GAP shares have outperformed major peers like Lululemon and Nike, rising approximately 15%.

image for news The Gap: Affordable Basics Are Winning The Day

NEOS Adds MLP & Energy Infrastructure Income ETF to Roster — Positive

IAUI  IYRI  QQQI  SPYI   ETF Trends — December 19, 2025

In an easing monetary policy environment, yields start to fall in line with rate cuts. Bond investors might be seeking to supplant the income they've grown accustomed to.

image for news NEOS Adds MLP & Energy Infrastructure Income ETF to Roster

Bitcoin ETF Landscape Shifts as U.S. Policy Changes — Positive

BRRR   ETF Trends — December 19, 2025

Bitcoin ETF investors are navigating a transformed policy environment in the United States, with the federal government designating the digital asset as a matter of national strategic importance, according to CoinShares' 2026 outlook report.

image for news Bitcoin ETF Landscape Shifts as U.S. Policy Changes

CHARLOTTE, N.C. , Dec. 19, 2025 /PRNewswire/ -- cbdMD, Inc. (NYSE American: YCBD), a leading wellness company and the parent of Herbal Oasis THC seltzers, ATRx functional mushroom supplements, and Paw CBD, today announces that it has entered into securities purchase agreements with institutional investors whereby Company issued the investors an aggregate of 1,000,000 shares of Series C Convertible Preferred Stock in consideration of gross proceeds to the Company of $2.25 million.

image for news cbdMD, Inc. Announces Closing of $2.25 Million Series C Preferred Stock Private Placement

Graham: A.I. & Fed Top 2026 Themes, Top Picks in ANET, COHR & LLY — Positive

LLY   Schwab Network — December 19, 2025

Andrew Graham says the next couple weeks will be hard to "separate the signal from the noise" in the A.I.-centric rebound due to low volume trading.

image for news Graham: A.I. & Fed Top 2026 Themes, Top Picks in ANET, COHR & LLY

NEW YORK, NY / ACCESS Newswire / December 19, 2025 / Cannabis did not design its infrastructure for permanence. It designed it for speed.

image for news Cannabis Is Running Into the Same Wall Plastics Already Hit, SMX Breaks Through it

NEW YORK, Dec. 19, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Inspire Medical Systems, Inc. (NYSE: INSP) between August 6, 2024 and August 4, 2025, both dates inclusive (the “Class Period”), of the important January 5, 2026 lead plaintiff deadline.

image for news INSP FINAL DEADLINE: ROSEN, A LEADING NATIONAL FIRM, Encourages Inspire Medical Systems, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INSP

SAN DIEGO--(BUSINESS WIRE)---- $PRGO #Health--Robbins LLP: Company: Perrigo Company (NYSE: PRGO) provides over-the-counter health and wellness solutions in the U.S., Europe, and internationally. What is the class period? February 27, 2024 - November 4, 2025 What is the Case About? Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who acquired Perrigo securities during the class period because the Company allegedly misled investors regarding the value of its infant formula.

image for news Did You Lose Money in Perrigo Company? PRGO Stockholders Should Contact Robbins LLP for Information About Their Rights Against PRGO.

SAN DIEGO--(BUSINESS WIRE)---- $SKYE #Biopharmaceutical--Robbins LLP: Company: Skye Bioscience, Inc. (NYSE: SKYE) is a clinical stage biopharmaceutical company that focuses on developing molecules that modulate G protein-coupled receptors (“GPCRs”) to treat obesity, overweight, and metabolic diseases. The Company's lead product candidate is nimacimab. What is the class period? November 4, 2024 - October 3, 2025 What is the case about? Robbins LLP reminds stockholders that a class action was filed on behalf of all investors.

image for news Did You Suffer Financial Loss in Skye Bioscience, Inc.? Stockholders Should Contact Robbins LLP for Information About Their Rights Against SKYE.

Why Nebius Rallied Today — Positive

NBIS   The Motley Fool — December 19, 2025

A key Nebius peer saw positive analyst coverage today, boosting the whole AI neocloud sector. Another Wall Street analyst idetified Nebius as a potential acquisition target in 2026.

image for news Why Nebius Rallied Today

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds investors there is a class action lawsuit on behalf of purchasers of common stock of James Hardie Industries plc (NYSE: JHX) between May 20, 2025 through August 18, 2025, both dates inclusive (the “Class Period”). James Hardie provides exterior home and outdoor living solutions. For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. The Allegations: Rosen Law Firm i.

image for news JHX Deadline: Rosen Law Firm Urges James Hardie Industries plc (NYSE: JHX) Stockholders to Contact the Firm for Information About Their Rights

SAN DIEGO--(BUSINESS WIRE)---- $JYD #Freight--Robbins LLP: Company: Jayud Global Logistics Limited (NASDAQ: JYD) claims to provide a range of worldwide cross-border supply chain solution services. What is the Class Period? April 21, 2023 - April 30, 2025 What is the case about? Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Jayud securities during the class period because the Company allegedly engaged in a fraudulent stock promotion s.

image for news Have You Incurred Financial Losses Due to Jayud Global Logistics Limited Stock Drop? Contact Robbins LLP for Information About the Action You Can Take Against JYD.

DraftKings CEO on entry to prediction markets: We'll be able to compete just fine — Positive

DKNG   CNBC Television — December 19, 2025

Jason Robbins, DraftKings CEO, joins 'The Exchange' to discuss DraftKings' entry into the prediction markets, the regulations behind it and much more.

image for news DraftKings CEO on entry to prediction markets: We'll be able to compete just fine

NEW YORK, Dec. 19, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Synopsys, Inc. (NASDAQ: SNPS) between December 4, 2024 and September 9, 2025, both dates inclusive (the “Class Period”), of the important December 30, 2025 lead plaintiff deadline.

image for news SNPS FINAL DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Synopsys, Inc. Investors to Secure Counsel Before Important December 30 Deadline in Securities Class Action - SNPS

Sagimet Biosciences Inc. remains a Strong Buy, driven by positive PK Denifanstat + Resmetirom combination data and advancing clinical programs in acne and MASH. SGMT's denifanstat plus resmetirom combo targets the untapped F4 MASH market, with phase 2 initiation anticipated in H2 2026 pending positive discussion with regulators. Ascletis' NDA acceptance in China for denifanstat in acne and SGMT's own TVB-3567 phase 1 progress strengthens the acne franchise.

image for news Sagimet: Positive Denifanstat Combination PK Data Could Lead To Untapped Market

NEW YORK, Dec. 19, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of CarMax, Inc. (NYSE: KMX) between June 20, 2025 and November 5, 2025, both dates inclusive (the “Class Period”) of the important January 2, 2026 lead plaintiff deadline in the securities class action first filed by the Firm.

image for news CARMAX IMPORTANT DEADLINE: ROSEN, A LONGSTANDING LAW FIRM, Encourages CarMax, Inc. Investors to Secure Counsel Before Important January 2 Deadline in Securities Class Action First Filed by the Firm – KMX

RAHWAY, N.J.--(BUSINESS WIRE)--Merck Reaches Agreement With U.S. Government to Expand Access to Medicines and Lower Costs for Americans.

image for news Merck Reaches Agreement With U.S. Government to Expand Access to Medicines and Lower Costs for Americans

Starbucks announced Friday that it has hired a new chief technology officer, Amazon veteran Anand Varadarajan. Varadarajan, who spent the last 19 years at Amazon, most recently led technology and supply chain for the tech giant's worldwide grocery stores business.

image for news Starbucks brings in new chief technology officer from Amazon Grocery

Stockholders have been notified of the Annual Meeting through mail, telephone/text, and email communications Bitmine leads crypto treasury peers by both the velocity of raising crypto NAV per share and by the high trading liquidity of BMNR stock Bitmine remains supported by a premier group of institutional investors including ARK's Cathie Wood, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital and personal investor Thomas "Tom" Lee to support Bitmine's goal of acquiring 5% of ETH LAS VEGAS , Dec. 19, 2025 /PRNewswire/ -- (NYSE AMERICAN: BMNR) Bitmine Immersion Technologies ("Bitmine" or the "Company") a Bitcoin and Ethereum …

image for news Bitmine Invites Stockholders to Attend its Annual Meeting Held in Las Vegas on January 15, 2026; Encourages Stockholders to Cast Their Votes

Diginex Is Powering Enforcement Where Compliance Is No Longer Voluntary — Neutral

DGNX   Accesswire — December 19, 2025

BOCA RATON, FL / ACCESS Newswire / December 19, 2025 / For more than a decade, corporate compliance operated on an honor system. Disclosures were published.

image for news Diginex Is Powering Enforcement Where Compliance Is No Longer Voluntary